IT1177968B - Recettori monoclonali, indotti da polipeptidi,per leganti proteinici - Google Patents

Recettori monoclonali, indotti da polipeptidi,per leganti proteinici

Info

Publication number
IT1177968B
IT1177968B IT48736/84A IT4873684A IT1177968B IT 1177968 B IT1177968 B IT 1177968B IT 48736/84 A IT48736/84 A IT 48736/84A IT 4873684 A IT4873684 A IT 4873684A IT 1177968 B IT1177968 B IT 1177968B
Authority
IT
Italy
Prior art keywords
polypeptides
induced
protein binders
monoclonal receptors
urine sample
Prior art date
Application number
IT48736/84A
Other languages
English (en)
Other versions
IT8448736A0 (it
IT8448736A1 (it
Inventor
Henry L Niman
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of IT8448736A0 publication Critical patent/IT8448736A0/it
Publication of IT8448736A1 publication Critical patent/IT8448736A1/it
Application granted granted Critical
Publication of IT1177968B publication Critical patent/IT1177968B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
IT48736/84A 1983-08-17 1984-08-17 Recettori monoclonali, indotti da polipeptidi,per leganti proteinici IT1177968B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52408483A 1983-08-17 1983-08-17

Publications (3)

Publication Number Publication Date
IT8448736A0 IT8448736A0 (it) 1984-08-17
IT8448736A1 IT8448736A1 (it) 1986-02-17
IT1177968B true IT1177968B (it) 1987-09-03

Family

ID=24087698

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48736/84A IT1177968B (it) 1983-08-17 1984-08-17 Recettori monoclonali, indotti da polipeptidi,per leganti proteinici

Country Status (9)

Country Link
EP (2) EP0592026A1 (it)
JP (2) JPS61500068A (it)
AT (1) ATE113962T1 (it)
AU (2) AU580738B2 (it)
CA (1) CA1219232A (it)
DE (1) DE3486356T2 (it)
IT (1) IT1177968B (it)
WO (1) WO1985000807A1 (it)
ZA (1) ZA846439B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972629A (en) 1984-08-17 1999-10-26 The Scripps Research Institute Method for characterizing antigenic reactivity of biological sample
US5591587A (en) * 1983-08-17 1997-01-07 The Scripps Research Institute Polypeptide-induced monoclonal receptors to protein ligands
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US5081230A (en) * 1987-07-08 1992-01-14 E. I. Dupont Denemours And Company Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
CA1296660C (en) * 1985-01-29 1992-03-03 Walter P. Carney Monoclonal antibody against a ras oncogene p21 related dodecapeptide
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
EP0203587A3 (en) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras oncogene peptides and antibodies
EP0206065A3 (en) * 1985-06-27 1989-04-19 James R. Feramisco Method of detecting oncogene and proto-oncogene related proteins in extracellular biological fluids
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1987001374A2 (en) * 1985-08-28 1987-03-12 George Pieczenik Method and means for sorting and identifying biological information
EP0269677A4 (en) * 1986-05-06 1990-03-08 Univ California ANALYZES AND ANTIBODIES OF N - i PROTEINS (myc).
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
JPH01502669A (ja) * 1987-03-13 1989-09-14 アムジエン・インコーポレーテツド 精製された血小板由来の成長因子及びその精製方法
EP0298450A3 (en) * 1987-07-07 1990-02-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
EP0370012A1 (en) * 1988-03-08 1990-05-30 E.I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
JPH0816679B2 (ja) * 1988-04-22 1996-02-21 オンコジーン・サイエンス・インコーポレーテッド 体液および組織におけるrasタンパクの検出、定量および分類
EP0354808B1 (en) * 1988-08-12 1997-12-03 Ligand Pharmaceuticals Incorporated Polypeptide-induced monoclonal receptors to protein ligands
ATE120860T1 (de) * 1990-01-26 1995-04-15 Washington Res Found Immunreaktivität gegenüber exprimierten aktivierten oncogenen zur diagnose und behandlung von bösartigen geschwülsten.
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002790A1 (en) * 1980-03-18 1981-10-01 Ciba Geigy Ag New solid supports for proteins for analytical purposes
EP0103893A3 (en) * 1982-09-22 1986-03-19 Daicel Chemical Industries, Ltd. Macrocyclic diesters
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
CA1339069C (en) * 1987-11-09 1997-07-29 Henry Lee Niman Polypeptide-induced monoclonal receptors to protein ligand
DE3854550T2 (de) * 1987-11-24 1996-04-25 Abbott Lab HIV-Peptide und Methoden für den Nachweis von HIV.

Also Published As

Publication number Publication date
EP0152477A4 (en) 1987-04-16
IT8448736A0 (it) 1984-08-17
WO1985000807A1 (en) 1985-02-28
AU3395084A (en) 1985-03-12
EP0152477A1 (en) 1985-08-28
DE3486356T2 (de) 1995-06-01
ATE113962T1 (de) 1994-11-15
ZA846439B (en) 1985-03-27
AU633253B2 (en) 1993-01-28
JPH07284398A (ja) 1995-10-31
EP0592026A1 (en) 1994-04-13
IT8448736A1 (it) 1986-02-17
AU580738B2 (en) 1989-02-02
EP0152477B1 (en) 1994-11-09
JPS61500068A (ja) 1986-01-16
AU3386089A (en) 1989-08-24
CA1219232A (en) 1987-03-17
DE3486356D1 (de) 1994-12-15
JP2592581B2 (ja) 1997-03-19

Similar Documents

Publication Publication Date Title
IT1177968B (it) Recettori monoclonali, indotti da polipeptidi,per leganti proteinici
FI891012A0 (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
DE3381781D1 (de) Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
EP0264219A3 (en) Receptors for immune complexes, their methods of production, compositions containing them, assay methods and assay kits using them
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
ES8405949A1 (es) Un ensayo
DE59009163D1 (de) Diagnostischer Nachweis unter Verwendung von chimären Antikörpern.
NO882204L (no) Ett-trinns immuntest for bestemmelse av antigenspesifikkeantistoffer fra en av immunoglobulinklassene a, m, d eller e og dertil egnet middel.
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ATE138205T1 (de) Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DE58907087D1 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz.
EP0392691A3 (en) Assays of coup-transcription factor interactions
ATE145480T1 (de) Verfahren zur bestimmung eines analyten
FR2582103B1 (fr) Procede de determination d'une substance biologique dans un echantillon
DE3650437D1 (de) Verfahren zum Messen von Freiliganden in biologischen Flüssigkeiten.
Abelev et al. Performance of multistep immunochemical reactions by counterflow isotachophoresis on nitrocellulose membranes—I. Immunoblotting
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
JPS57132897A (en) Quantitative measurement of ligand
ATE40475T1 (de) Verbesserter immunoassay zur bestimmung von antikoerpern gegen native-dna.
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
ATE44980T1 (de) Immunologisches verfahren zum nachweis von brustkrebs durch verwendung von monoklonalen antikoerpern.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950831